Capital Fund Management (CFM)
JAZZ icon

Capital Fund Management (CFM)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Capital Fund Management (CFM)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-28,000
Closed -$4.82M – 2102
2018
Q2 		$4.82M Buy
28,000
+26,600
+1,900% +$4.35M 0.03% 752
2018
Q1 		$211K Buy
+1,400
New +$205K ﹤0.01% 1750
2015
Q1 		– Sell
-9,200
Closed -$1.51M – 1591
2014
Q4 		$1.51M Sell
9,200
-2,400
-21% -$398K 0.02% 772
2014
Q3 		$1.86M Sell
11,600
-9,300
-44% -$1.43M 0.02% 704
2014
Q2 		$3.07M Sell
20,900
-4,900
-19% -$680K 0.03% 580
2014
Q1 		$3.58M Buy
+25,800
New +$3.88M 0.04% 470

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Capital Fund Management (CFM)'s JAZZ Position: Q3 2025 in Review

Capital Fund Management (CFM) sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 40,275 shares — an estimated $4.27M sold.

Capital Fund Management (CFM) first reported a position in JAZZ in Q1 2014 and held it in 19 quarters. The position peaked at $10.4M in Q2 2016. 502 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Capital Fund Management (CFM) reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 40,275 Jazz Pharmaceuticals shares in Q3 2025, an estimated $4.27M.
  • Capital Fund Management (CFM) first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 19 quarters.
  • Capital Fund Management (CFM)'s Jazz Pharmaceuticals position peaked at $10.4M in Q2 2016.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.